Actively Recruiting
Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome
Led by Mario Negri Institute for Pharmacological Research · Updated on 2025-09-04
100
Participants Needed
1
Research Sites
206 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This retrospective study is aimed at evaluating the levels of circulating anti-nephrin autoantibodies in patients with INS, including those with MCD/FSGS and in patients who have experienced relapse of FSGS post-transplant, compared to those of a control group of patients with nephrotic syndrome due to primary membranous nephropathy (MN).
CONDITIONS
Official Title
Autoantibodies Against-nephrin in Idiopathic Nephrotic Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults older than 18 years
- Patients with biopsy-confirmed idiopathic minimal change disease or focal segmental glomerulosclerosis
- Patients with biopsy-confirmed idiopathic membranous nephropathy
- Patients who consented to store their samples in the certified biobank
You will not qualify if you...
- Possible secondary cause of nephrotic syndrome or membranous nephropathy at the time of blood collection
- Active viral or bacterial infections at the time of blood collection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinical Research Center for Rare Disease Aldo e Cele Daccò
Ranica, BG, Italy, 24020
Actively Recruiting
Research Team
F
Federica Casiraghi, PhD
CONTACT
N
Norberto Perico, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here